Cure Ventures Fund I, L.P. — Form D/A
Cure Ventures Fund I, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-04-04. The offering totals $350.5M, of which $350.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-04-04
- Form: D/A
- Accession: 0001863564-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $350.5M
- Amount sold: $350.5M
- Investors: 44
- Date of first sale: 2021-05-25
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-400415
Issuer
- Name: Cure Ventures Fund I, L.P.
- CIK: 0001863564
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 351 NEWBURY STREET, 2ND FLOOR, BOSTON, MA, 02115
- Phone: 970-759-6000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| N/A Cure Ventures Fund I GP, LLC | Executive Officer | Boston, MA |
| Dave Fallace | Executive Officer | Boston, MA |
| Richard J Lim | Executive Officer | Billerica, MA |
| Louis J Tartaglia | Executive Officer | Boston, MA |
| Lou J Tartaglia | Executive Officer | FRAMINGHAM, MA |
Other filings by this issuer (2)
More